News
AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and ...
Astronomy on MSN
Would Americans be healthier without daylight saving time?
Every spring, most Americans dutifully adjust their clocks forward to daylight saving time, and every fall, back to standard ...
Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...
AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback